CVS Health (NYSE:CVS) Given New $59.00 Price Target at UBS Group

CVS Health (NYSE:CVS) had its price objective decreased by UBS Group from $62.00 to $59.00 in a research report released on Tuesday. UBS Group currently has a neutral rating on the pharmacy operator’s stock.

Other analysts have also issued reports about the company. Barclays lowered their target price on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. Mizuho lowered their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Evercore ISI lifted their target price on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday, January 27th. TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research note on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, six have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $67.78.

CVS Health Stock Up 1.3 %

CVS Health stock opened at $55.01 on Tuesday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $69.23 billion, a P/E ratio of 13.96, a P/E/G ratio of 0.60 and a beta of 0.61. The firm has a 50 day moving average price of $50.69 and a 200-day moving average price of $55.95. CVS Health has a twelve month low of $43.56 and a twelve month high of $80.75.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.84%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Institutional Investors Weigh In On CVS Health

A number of large investors have recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. purchased a new stake in shares of CVS Health in the 3rd quarter valued at $25,000. Ridgewood Investments LLC increased its holdings in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the period. Stonebridge Financial Group LLC purchased a new stake in CVS Health during the 4th quarter valued at about $28,000. Hopwood Financial Services Inc. purchased a new position in CVS Health in the 4th quarter worth approximately $29,000. Finally, Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter valued at approximately $31,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.